| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |